Ana García‐Noblejas

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Anna Sureda, Carmen Canals, R. Arranz et al. · Haematologica · 2011 · 210 citations · Full text

Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: A Matched Case-Control Study

Núria Sabé, Carlos Cervera, María Carmen Fariñas et al. · Clinical Infectious Diseases · 2011 · 140 citations · Full text

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Nuria Tormo, Carlos Solano, Isabel Benet et al. · Bone Marrow Transplantation · 2011 · 63 citations

Transplantation, Cmv Dnaemia, Medicine +12

Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico

Guillermo Ortí, Jaime Sanz, Arancha Bermúdez et al. · Biology of Blood and Marrow Transplantation · 2015 · 61 citations · Full text

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Nuria Tormo, Carlos Solano, Isabel Benet et al. · Bone Marrow Transplantation · 2009 · 56 citations

Cell Therapy, Transplantation, Immunodeficiencies +12